CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-18 | Bode John B Director | Purchase | +100 | $5.05 | $505 | 7,549 |
| 2023-05-18 | Bode John B Director | Purchase | +2,451 | $5.05 | $12K | 10,000 |
| 2023-05-18 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +51 | $4.94 | $252 | 11,053 |
| 2023-05-18 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +2,000 | $4.95 | $10K | 13,053 |
| 2023-05-18 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +689 | $4.95 | $3K | 13,742 |
| 2023-05-03 | Calder Douglas W Director | Grant or award · Stock Option (right to buy) | +58,800 | 58,800 | ||
| 2023-05-03 | Watton Corey Michael Director | Grant or award · Stock Option (right to buy) | +58,800 | 58,800 | ||
| 2023-05-03 | DIXON WENDY L Director | Grant or award · Stock Option (right to buy) | +36,300 | 36,300 | ||
| 2023-05-03 | Bode John B Director | Grant or award · Stock Option (right to buy) | +58,800 | 58,800 | ||
| 2023-04-25 | Saluri Joseph Director | Grant or award · Stock Option (right to buy) | +39,200 | 39,200 | ||
| 2023-04-25 | Plooster Matthew R Director | Grant or award · Stock Option (right to buy) | +49,200 | 49,200 | ||
| 2023-04-25 | FAVORITO TAMARA A Director | Grant or award · Stock Option (right to buy) | +39,200 | 39,200 | ||
| 2023-04-25 | DIXON WENDY L Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2023-03-17 | SEYMOUR TAMARA A Director | Purchase | +519 | $4.82 | $3K | 719 |
| 2023-03-14 | Schafer Joshua CCO & EVP, Bus. Development | Purchase | +2,000 | $4.61 | $9K | 2,000 |
| 2023-03-10 | Sangiovanni Timothy J. SVP, Corporate Controller | Purchase | +1,100 | $4.14 | $5K | 4,349 |
| 2023-03-10 | Sangiovanni Timothy J. SVP, Corporate Controller | Purchase | +100 | $4.14 | $414 | 4,449 |
| 2023-03-10 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +1,725 | $4.15 | $7K | 11,002 |
| 2023-03-09 | Plooster Matthew R Director | Purchase | +11,000 | $4.20 | $46K | 18,500 |
| 2023-03-09 | Tierney David S Director | Purchase | +5,000 | $4.15 | $21K | 10,835 |
Page 8 of 9 · 166 trades